No Data
No Data
FibroBiologics, Charles River Establish Master Services Agreement
Express News | Fibrobiologics Inc: Cywc628, for Utilization in a Diabetic Foot Ulcer (Dfu) Clinical Trial Slated to Begin in 2025.
FibroBiologics and Charles River Announce Collaboration to Manufacture Fibroblast Cell-based Therapies for Chronic Diseases
Express News | Fibrobiologics and Charles River Announce Collaboration to Manufacture Fibroblast Cell-Based Therapies for Chronic Diseases
Charles River Launches New Retrogenix Non-Human Protein Library
Charles River Laboratories Schedules Third-Quarter 2024 Earnings Release and Conference Call
No Data
No Data